Bioreactor Amplification of Recombinant Cell Lines

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for amplifying recombinant cell lines to express polypeptides of interest are labor-intensive and time-consuming, often requiring several months and continuous monitoring to achieve desired amplification levels.

Innovation Solution

The use of a bioreactor for culturing host cells transfected with nucleic acid sequences encoding a polypeptide of interest and an amplifiable marker, with increasing concentrations of an amplification agent to rapidly amplify and express the polypeptide, reducing the time and labor required for cell line development.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional amplification methods using tissue culture flasks, shake flasks, or spinner flasks are used, then cell lines can be amplified, but the process requires several months and is labor-intensive due to continuous monitoring requirements

Engineering Contradiction:
Improveamplification speedVSAvoidtime required for amplification
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention changes the physical parameters of the culture system by transitioning from small-scale flask cultures to large-scale bioreactor cultures. This parameter change enables automated monitoring and control, reducing manual intervention while accelerating the amplification process from several months to a more efficient timeframe.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces manual mechanical operations (continuous monitoring, sampling, and manipulation in flasks) with automated bioreactor systems that can monitor and control amplification processes automatically, thereby reducing labor intensity and time requirements.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of manufacture

If sequential step-wise increases in amplification agent concentration are applied in traditional flasks, then amplification can be achieved, but the process is labor-intensive requiring continuous evaluation over several months

Engineering Contradiction:
Improveease of amplification processVSAvoidoperational simplicity
Core Design Contradiction:
Ease of manufactureVSEase of operation

Solution Approach 1:

The bioreactor system is designed to automatically monitor cell growth and amplification parameters, and can autonomously adjust amplification agent concentrations according to pre-programmed protocols. This self-service capability eliminates the need for continuous manual evaluation and adjustment, making the process easier to operate while maintaining amplification effectiveness.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention implements continuous automated monitoring and control of the amplification process in bioreactors, replacing the discontinuous manual sampling and evaluation required in traditional flask methods. This continuous action ensures optimal conditions are maintained throughout the amplification process without requiring intermittent human intervention.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces the time needed to produce amplified cell lines by up to 60%, making the process more efficient and less labor-intensive, while also preparing cells for subsequent bioreactor culturing by exposing them to shear stress conditions.

Implementation Method 1

preparing cells for subsequent bioreactor culturing by exposing them to shear stress conditions

Methodology Applied
Scientific EffectShear stress: Shear Stress

Data Source

PatentUS8357514B2Methods of gene amplification and expression
Publication Date: 2013.01.22 ER SQUIBB & SONS LLC
  • US8357514B2 patent drawing
  • US8357514B2 patent drawing
  • US8357514B2 patent drawing

AI summary

Disclosed are methods relating to amplification and expression of a nucleic acid sequence encoding a polypeptide of interest in recombinant cells, and cell lines and polypeptides produced from such methods. The methods disclosed herein permit the amplification of cell lines that express a polypeptide of interest in a relatively short period of time through the use of a bioreactor.